Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems

Publisher Website
Google Scholar
Abstract
The genotoxic potency of certain classes of topoi some rase II poisons is correlated with their affinity to the topoisomerase protein rather than with the presence of ‘classical’ structural alerts for DNA reactivity: bacterial topoisomerase II poisons (specifically named gyrase inhibitors) are highly genotoxic in prokaryotic systems; mammalian topoisomerase II poisons are potent mutagens/clastogens in eukaryotic systems. Studies with bacterial, lower eukaryotic and mammalian genotoxicity tests were performed to draw structure-activity conclusions and address risk-benefit considerations for the class of quinolone gyrase inhibitors. AII 17 gyrase inhibitors investigated in this study showed genotoxic activity in Salmonella typhimurium strain TA 102 and the SOS test. The genotoxic and the toxic activities increased in a highly parallel fashion from the parent compounds, nalidixic acid and oxoliniv acid, to the new generation fluoroquinolones. Generally, the most potent fluoroquinolones also show clear-cut positive effects in eukaryotic test systems, although at concentrations 100–1000-fold higher than those effective in bacteria and also 100–1000-fold higher than the minimal genotoxic concentrations of antitumour topoisomerase II inhibitiors (ellipticine, teniposide, mAMSA) used as reference compounds. However, subtle structural modifications of the quinolones can strongly diminish the preferential genotoxicity in the prokaryotic test systems.

This publication has 0 references indexed in Scilit: